@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix scomp: . @prefix ProteinComplex: . @prefix go: . @prefix Protein: . @prefix hgnc: . @prefix geneProductOf: . @prefix hasAgent: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { scomp:HDL%20Complex a ProteinComplex: . sub:_1 hasAgent: sub:_2; a go:0003824 . sub:_2 geneProductOf: hgnc:7876; a Protein: . sub:_3 occursIn: obo:UBERON_0001986, species:9606; rdf:object sub:_1; rdf:predicate belv:increases; rdf:subject scomp:HDL%20Complex; a rdf:Statement . sub:assertion rdfs:label "complex(SCOMP:\"HDL Complex\") -> cat(p(HGNC:NOS3))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_5; pav:version "20131211" . sub:_4 prov:value "High-density lipoproteins (HDLs), whose plasma levels are reduced in cirrhosis, have an anti-inflammatory effect by neutralizing circulating lipopolysaccharide (LPS), and they increase eNOS activity in endothelial cells."; prov:wasQuotedFrom pubmed:17918268 . sub:_5 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:17918268; prov:wasDerivedFrom beldoc:, sub:_4 . } sub:pubinfo { this: dct:created "2014-07-03T14:33:12.999+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }